Effectiveness of CKD Exacerbation Countermeasures in Izumo City
To diagnose chronic kidney disease (CKD) at an early stage, it is important to promote appropriate health guidance and consultation recommendations through regular medical examinations and implementation of continuous high-quality and appropriate treatment. From fiscal year (FY) 2018, Izumo City has initiated the "Izumo City CKD Exacerbation Countermeasures" program. In this study, we aimed to report on the methods undertaken and the effects of this program. Residents aged 40-74 years who underwent specific health checkups from the Izumo City National Health Insurance in FY2018 and FY2019 were included. The rates of CKD re-examination candidates, re-examinations implementation, nephrologist referrals, and health guidance referrals between FY2018 and FY2019 were compared. The rate of CKD re-examination candidates in both years remained unchanged at approximately 7%. The rate of re-examination implementation in FY2019 significantly increased relative to that in FY2018 (p < 0.001). Subsequent re-examination candidate trends showed that the rate of nephrologist referrals did not increase. However, the rate of city health guidance referrals significantly increased (p < 0.001). Increase in the re-examination and health guidance examination rates indicate improved awareness of CKD among the public and family doctors, and it is expected to prevent CKD exacerbation in the future.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Journal of personalized medicine - 11(2021), 11 vom: 28. Okt. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ito, Takafumi [VerfasserIn] |
---|
Links: |
---|
Themen: |
CKD exacerbation |
---|
Anmerkungen: |
Date Revised 30.11.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jpm11111104 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333715772 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333715772 | ||
003 | DE-627 | ||
005 | 20231225222220.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jpm11111104 |2 doi | |
028 | 5 | 2 | |a pubmed24n1112.xml |
035 | |a (DE-627)NLM333715772 | ||
035 | |a (NLM)34834456 | ||
035 | |a (PII)1104 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ito, Takafumi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effectiveness of CKD Exacerbation Countermeasures in Izumo City |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.11.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a To diagnose chronic kidney disease (CKD) at an early stage, it is important to promote appropriate health guidance and consultation recommendations through regular medical examinations and implementation of continuous high-quality and appropriate treatment. From fiscal year (FY) 2018, Izumo City has initiated the "Izumo City CKD Exacerbation Countermeasures" program. In this study, we aimed to report on the methods undertaken and the effects of this program. Residents aged 40-74 years who underwent specific health checkups from the Izumo City National Health Insurance in FY2018 and FY2019 were included. The rates of CKD re-examination candidates, re-examinations implementation, nephrologist referrals, and health guidance referrals between FY2018 and FY2019 were compared. The rate of CKD re-examination candidates in both years remained unchanged at approximately 7%. The rate of re-examination implementation in FY2019 significantly increased relative to that in FY2018 (p < 0.001). Subsequent re-examination candidate trends showed that the rate of nephrologist referrals did not increase. However, the rate of city health guidance referrals significantly increased (p < 0.001). Increase in the re-examination and health guidance examination rates indicate improved awareness of CKD among the public and family doctors, and it is expected to prevent CKD exacerbation in the future | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a CKD exacerbation | |
650 | 4 | |a Kidney Disease Countermeasures Study Group Report | |
650 | 4 | |a chronic kidney disease | |
650 | 4 | |a medical care system | |
650 | 4 | |a specific health checkup | |
700 | 1 | |a Kamei, Fumika |e verfasserin |4 aut | |
700 | 1 | |a Sonoda, Hirotaka |e verfasserin |4 aut | |
700 | 1 | |a Oba, Masafumi |e verfasserin |4 aut | |
700 | 1 | |a Kawanishi, Miharu |e verfasserin |4 aut | |
700 | 1 | |a Yoshimura, Ryuichi |e verfasserin |4 aut | |
700 | 1 | |a Fukunaga, Shohei |e verfasserin |4 aut | |
700 | 1 | |a Egawa, Masahiro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of personalized medicine |d 2011 |g 11(2021), 11 vom: 28. Okt. |w (DE-627)NLM228113881 |x 2075-4426 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:11 |g day:28 |g month:10 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jpm11111104 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 11 |b 28 |c 10 |